Compared to Estimates, OPKO Health (OPK) Q2 Earnings: A Look at Key MetricsZacks Investment Research • 07/27/26
OPKO Health Reports Second Quarter 2026 Business Highlights and Financial ResultsGlobeNewsWire • 07/27/26
Preclinical Data for OPKO Biologics' OPK8801001 in Acromegaly Presented at ENDO 2026GlobeNewsWire • 06/15/26
OPKO Health (OPK) Up 17.1% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 05/28/26
OPKO Health's ModeX Therapeutics Will Present Data Demonstrating In Vivo CAR-T Cell Generation and Deep B-Cell Depletion in Preclinical StudiesGlobeNewsWire • 05/12/26
OPKO Health Expands Nicoya Agreement to Support RAYALDEE® Commercialization in Greater ChinaGlobeNewsWire • 04/30/26
BioReference® Launches BioReference Direct™, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital PlatformGlobeNewsWire • 04/30/26
OPKO Health Q1 Earnings In-Line on Product Gains, Revenues Down Y/YZacks Investment Research • 04/29/26
OPKO Health (OPK) Q1 Earnings: How Key Metrics Compare to Wall Street EstimatesZacks Investment Research • 04/29/26
OPKO Health Reports First Quarter 2026 Business Highlights and Financial ResultsGlobeNewsWire • 04/28/26
OPKO Health's ModeX Therapeutics Begins Clinical Trial of Tetraspecific Antibody for Treatment of B-cell LymphomasGlobeNewsWire • 04/22/26
OPK Q4 Earnings & Revenues Beat Estimates, Gross Margin ContractsZacks Investment Research • 02/27/26
Compared to Estimates, OPKO Health (OPK) Q4 Earnings: A Look at Key MetricsZacks Investment Research • 02/27/26
OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial ResultsGlobeNewsWire • 02/26/26
Can OPKO Health's Pipeline Progress and Deals Drive Growth in 2026?Zacks Investment Research • 02/18/26